Philip Supply is an expert in Infectiology at Centre Hospitalier Universitaire de Lille (France). Philip Supply has authored 156 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 507 (community average: 125). How the SLR is computed.

LeadR Profile

507 ScienceLeadR Reputation 507
Network Map

Infectiology

Subspecialties: Genetics - Public Health - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

Pasteur Institute of Lille

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 156

Citations

Citations: 14 916 1st author: 14 Last author: 31 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Melting temperature signatures reveal occasional misclassification of low-level isoniazid resistance by Xpert MTB/XDR.
PMID 42496145 — isoniazid, temperature
Microbiol Spectr20260
Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial.
PMID 38762282 — leprosy, incidence, global health, post-exposure prophylaxis, rifampin
Lancet Glob Health20249
Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
PMID 38537504 — research design, communicable diseases, microbiology, clinical laboratory techniques, pharmaceutical preparations, mycobacterium tuberculosis, high-throughput nucleotide sequencing, whole genome sequencing
Diagn Microbiol Infect Dis20244
Newly Identified Mycobacterium africanum Lineage 10, Central Africa.
PMID 38407162 — respiratory tract infections, bacteria, mycobacterium, communicable disease control, genome
Emerg Infect Dis202420
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.
PMID 38216576 — biological science disciplines, research design, pharmaceutical preparations, mutation, genes, mycobacterium tuberculosis
Nat Commun202423

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map